Value proposition

Saving Time, Saving Life.

HiberGene Diagnostics is a Dublin-based, private Irish company, that develops, manufactures and markets molecular diagnostic tests for the direct detection of human infectious diseases, using the LAMP (Loop Mediated Isothermal Amplification) technology.

In May 2020, HiberGene successfully completed the CE marking of a new fast molecular COVID-19 test. The new COVID-19 test, which expands the company’s product range to 13 tests. Positive results are returned within a few hours, enabling rapid diagnosis of the disease at the early and highly infectious stage of infection.

With its expanding HG product line, HiberGene is committed to providing rapid and highly accurate testing solutions, which are cost effective and simple to use. Current HG products include molecular tests for Covid-19, Meningococcus, Group B Streptococcus (GBS), C. difficile and Mycyplasma pneumoniae. HG tests address the unmet clinical need for a rapid, highly accurate and simple testing solution, making them ideal for use in a wide range of clinical, near patient and laboratory environments.

Molecular Diagnostics, LAMP technology, Human Infectious Diseases, Meningococcus, Group B Streptococcus, C. difficile, Mycoplasma pneumoniae, Pneumococcus, Diagnostics, and Covid-19 Testing